ADHD, explained

Adult ADHD usually shows up as chronic distractibility, disorganization, procrastination, forgetfulness, restlessness, and impulsivity that have been present since childhood and cause real problems in more than one area of life. Adults often show less physical hyperactivity than kids; instead it feels like a racing mind, trouble finishing what you start, and exhaustion from holding systems together. If several of these sound familiar, a comprehensive evaluation can give you a real answer.

Laziness is not a medical condition, and it doesn’t explain wildly inconsistent performance. The ADHD pattern looks like this: you can perform brilliantly when something is interesting or urgent, then be unable to start a simple boring task for days, no matter how much you care. Lazy people don’t build elaborate coping systems or lie awake ashamed of unfinished to-do lists. If you’re working twice as hard to look average, that’s worth evaluating, not moralizing.

Free online screeners exist, and the best-validated one is the six-question ASRS from the World Health Organization, but no online quiz can diagnose ADHD. Screeners only tell you whether a full evaluation is worth pursuing. Quizzes on social media are entertainment, not medicine. If a screener or this page keeps ringing true, the next step is a real diagnostic workup: a clinical interview, validated rating scales, and objective testing, which is exactly what the evaluation here includes.

By definition, ADHD begins in childhood, with symptoms present before age 12, but it is extremely common for it to go unrecognized until adulthood. According to CDC data, more than half of adults with an ADHD diagnosis (55.9%) were diagnosed as adults. What usually changes isn’t your brain; it’s your load. School structure hides symptoms that a career, a household, and parenting expose. If focus problems appeared truly out of nowhere in adulthood, other causes like sleep disorders, thyroid problems, or depression deserve a careful look first.

High-functioning ADHD is an informal term for people who meet full criteria for ADHD but perform well enough at work or school that nobody ever suspected it. It isn’t a separate diagnosis, and the term hides the real cost: the constant compensating, late nights, and anxiety that keep the performance up. There’s a full article about it: High-Functioning ADHD: When Doing Well Hides What’s Hard.

Because screening keyed on visible disruption, and you weren’t disruptive. Kids with good grades, quiet inattentive symptoms, or strong intelligence routinely slipped through, especially girls. Teachers referred the kid climbing furniture, not the one daydreaming through class with B-plus grades. Recognition often arrives decades later, commonly when your own child gets evaluated and the questionnaire starts describing you.

ADHD itself doesn’t progressively worsen like a degenerative disease, but symptoms often become more disruptive as life demands more executive function: careers, homes, finances, kids. Symptoms persist into adulthood in roughly three out of four childhood cases. Many adults also notice a real worsening during high-stress seasons and, for women, during perimenopause when estrogen shifts affect focus.

Executive function is the brain’s management system: planning, prioritizing, starting tasks, holding information in mind, and regulating impulses. Executive dysfunction means those processes fire unreliably, which is the core of ADHD. It’s why a person can be intelligent and motivated yet unable to start a tax return, keep track of a passport, or stop scrolling at 1am on a work night.

Hyperfocus is actually characteristic of ADHD, not evidence against it. ADHD is a disorder of regulating attention, not lacking it. Interest, novelty, and urgency can lock an ADHD brain onto a task for hours, while important-but-boring tasks remain impossible to start. If your focus works brilliantly but only on its own terms, that pattern points toward ADHD rather than away from it.

ADHD paralysis, sometimes called task paralysis or ADHD shutdown, is the experience of being unable to start anything despite knowing exactly what needs to happen, often while feeling increasing panic about it. It usually strikes when a task feels boring, ambiguous, or overwhelming. It isn’t a character flaw; it’s executive dysfunction, and it responds to treatment and to strategies like shrinking the first step and adding external structure.

Untreated ADHD tends to compound: higher rates of anxiety, depression, job instability, financial stress, relationship strain, car accidents, and substance use. Roughly a third of adults with ADHD receive no treatment in a given year. The good news is that treatment meaningfully reduces these risks, and it’s never too late to start. Adults diagnosed at 45 or 60 still benefit.

Social media is genuinely good at describing relatable ADHD moments and genuinely bad at diagnosis; studies have found that over half of popular ADHD content contains inaccurate claims. The honest path is a structured evaluation: your full history, validated rating scales, objective computerized testing, and screening for conditions that mimic ADHD. That’s a 90-minute process here, and if the answer is no, you’ll get an honest explanation of what’s actually going on.

The evaluation fee covers the diagnostic work, not a particular answer, and a clear “this isn’t ADHD, here’s what fits better” is a genuinely valuable result. You leave with written findings, an explanation of the most likely cause of your symptoms, and either a treatment plan here or a referral pointed at the right problem. Details on fees live on the Fees & Payment page.

Adult ADHD is diagnosed clinically: a detailed interview covering your history from childhood forward, validated rating scales, and screening to rule out look-alike conditions, measured against the DSM-5 criteria (five or more symptoms, present before age 12, in two or more settings, causing real impairment). There is no blood test or brain scan. Good clinics add objective computerized testing to bring hard data into the picture, which is how it works here.

You can book an adult ADHD evaluation directly with Maine ADHD Clinic by telehealth from anywhere in the state, with no referral, usually within days. Start with a free 15-minute phone call through the contact page. The alternative route, an in-person evaluation through Maine’s hospital systems, is thorough but commonly involves a six-to-nine-month wait. The new patients page walks through every step.

Three steps. Before your visit, you complete intake forms, MindMetrix (a broad psychiatric prescreen), and Creyos cognitive testing from home. Then a 90-minute structured clinical interview by secure video covering your whole history. Finally, a 30 to 45 minute results and treatment alignment visit, where I walk you through what the testing showed and we decide next steps together. Results are not reviewed during the evaluation itself.

The core evaluation visit here is 90 minutes, plus about 30 minutes of forms and rating scales you complete from home beforehand, and a follow-up results visit. First call to written answers typically takes a few weeks. Compare that with the six-to-nine-month waits common for in-person evaluations in Maine.

No. Despite what some clinics advertise, no brain scan, blood test, or genetic test can diagnose ADHD. Research shows average group differences on imaging, but nothing accurate enough to diagnose an individual. Diagnosis is clinical: history, validated scales, and symptom criteria, ideally supplemented with objective computerized performance testing. Be skeptical of anyone selling an ADHD scan.

Objective computerized ADHD tests measure inattention, impulsivity, and activity level during a structured task, then compare performance against norms for your age and sex. Combined with a full clinical evaluation, this kind of testing meaningfully improves diagnostic accuracy. It’s an aid to diagnosis, never a standalone verdict — there’s no pass or fail.

No. Maine ADHD Clinic takes self-referrals; you can simply call. Some hospital-system clinics in Maine require a referral from a primary care provider, which adds a step and a wait, but no law requires one for a psychiatric evaluation.

Helpful, not required. Old report cards or a parent’s memories strengthen the childhood-evidence picture, and an observer rating scale from someone who knew you young is genuinely useful. But plenty of adults have no records and no living informants, and evaluations proceed anyway; your own detailed history carries the diagnosis when it’s consistent.

Yes. A board-certified psychiatric-mental health nurse practitioner (PMHNP-BC) is trained and licensed to diagnose ADHD and prescribe the full range of ADHD medications. Maine grants nurse practitioners full independent practice authority, including Schedule II prescribing. Audrey Farley, PMHNP-BC is board certified through ANCC and Maine licensed; her background is on the About page.

Usually not for ADHD alone. International research consensus says ADHD is diagnosed through a clinical interview and history, and no single test, including neuropsychological testing, can diagnose it or rule it out. Full neuropsychological testing is built for other questions: dementia, stroke, brain injury, and learning disorders. It can also mean long waits, sometimes a year or more, and costs in the thousands, and some practices limit or decline evaluations for ADHD alone. If your history points to something that needs it, I’ll tell you and help you find it.

No. There’s nothing to pass or fail and no way to prepare. The evaluation is a structured way of understanding how your attention actually works and where your symptoms come from. Every outcome gives you something: either a diagnosis with a plan, or a clear explanation of what’s more likely driving your symptoms.

It’s understandable to worry that testing will be a waste if the results don’t support an ADHD diagnosis. But ruling out ADHD can be just as valuable as identifying it. An evaluation may show that attention difficulties are more closely related to anxiety, depression, sleep disruption, stress, or another condition. Sometimes ADHD is present along with one or more additional concerns. Whatever the outcome, the purpose of the evaluation is a clearer understanding of what’s happening and what may help.

The big ones: anxiety disorders (a worried mind that can’t settle), depression (drained motivation and slowed thinking), sleep disorders including apnea and chronic insomnia, thyroid dysfunction, perimenopause, trauma responses, bipolar disorder, and plain unsustainable life load. Several of these also co-occur with ADHD, which is why a real evaluation screens for them instead of assuming.

Many PCPs are uncomfortable diagnosing adult ADHD or prescribing controlled substances without a specialist evaluation, and some health systems restrict it outright. It’s not personal; adult ADHD assessment takes time a 15-minute visit doesn’t have. A specialist evaluation with documentation often solves this: some patients return to their PCP for ongoing prescribing with the diagnosis established, and others simply continue care here.

ADHD without the stereotype. Inattentive ADHD often looks quiet from the outside. The struggle is internal: chronic procrastination, even on things that matter; mental fatigue from constantly managing your own attention; executive dysfunction, meaning trouble starting, planning, and finishing; and a wandering mind, even when you’re trying to focus. Because nothing looks disruptive, it’s easy to miss for years.

You can’t tell from symptoms alone. Both can cause trouble concentrating, mental exhaustion, and difficulty starting tasks. I look at when symptoms began, whether they were present in childhood, and what else is going on. Sometimes it’s ADHD, sometimes anxiety or depression, and sometimes both.

There is no single best medication; there’s a best medication for you, found systematically. Stimulants (methylphenidate and amphetamine families) are the most effective for most adults, helping roughly 70 to 80 percent. Non-stimulants (atomoxetine, viloxazine, guanfacine) are the better fit for some people. The choice depends on your health history, co-occurring conditions, and preferences, decided after an evaluation confirms the diagnosis.

Stimulants work within an hour and wear off the same day, making them adjustable but scheduled; they’re controlled substances and the most effective option for most adults. Non-stimulants build effect gradually over weeks, run around the clock, aren’t controlled substances, and can be the smarter choice with certain heart conditions, anxiety, substance-use history, or personal preference. Both are legitimate paths, and both are used at this practice when clinically appropriate.

Stimulants increase the availability of dopamine and norepinephrine in brain circuits that manage attention and impulse control. In an ADHD brain, that’s less like caffeine and more like glasses for the mind’s focus: tasks require less white-knuckling to start and stay with. Effects begin within about an hour and last from 4 to around 12 hours depending on the formulation.

Prescription stimulants are controlled substances precisely because misuse can lead to dependence, but taken as prescribed at therapeutic doses under medical supervision, addiction risk is low, and research suggests treating ADHD actually lowers overall substance-use risk. The danger zone is escalating doses on your own or using someone else’s medication. Good prescribing includes monitoring, honest conversations about your history, and non-stimulant alternatives when they’re the wiser choice.

Both are amphetamine-based stimulants. Adderall contains mixed amphetamine salts and comes in immediate and extended release; Vyvanse (lisdexamfetamine) is a prodrug your body converts gradually, giving a smoother, longer effect (10 to 14 hours) with less abuse potential and, often, less peak-and-crash feeling. Vyvanse’s generic has also eased its cost and supply. Which fits you depends on coverage needs, sensitivity to peaks, and how your body responds.

For stimulants: reduced appetite, trouble falling asleep, dry mouth, headache, mild heart-rate or blood-pressure increases, and sometimes irritability as a dose wears off. Most are manageable with dose, timing, and formulation adjustments, which is what titration visits are for. Non-stimulants have their own profiles, like initial fatigue or nausea with atomoxetine. Monitoring is built into care here, including blood pressure checks.

No, and this is a persistent myth. Low-dose stimulants improve focus in most people, ADHD or not, so a calming response proves nothing diagnostically. The reverse is also true: a bad reaction to one stimulant doesn’t rule ADHD out. Diagnosis comes from history, criteria, and testing, never from a medication trial.

Immediate-release stimulants last roughly 3 to 6 hours; extended-release formulations run 8 to 14 hours depending on the product and the person. Non-stimulants provide steady coverage around the clock once established. Matching coverage to your actual day, work hours, evening parenting, safe driving, is part of choosing and tuning the prescription.

You should notice tasks starting with less internal warfare: emails answered when read, projects begun before the panic deadline, conversations tracked without rereading, the mental noise turned down. What it shouldn’t feel like is being wired or emotionally flattened. We define target symptoms before starting, then measure against them at follow-ups and adjust. If you feel nothing at all, that’s data too, and doses or medications get changed.

The main FDA-approved options are atomoxetine (Strattera), viloxazine (Qelbree), and extended-release guanfacine (Intuniv). Bupropion (Wellbutrin) is sometimes used off-label, particularly when depression co-occurs. They’re not controlled substances, don’t require monthly prescriptions, and can be the right first choice for several clinical situations, not just a consolation prize.

Give it 4 to 8 weeks at a therapeutic dose before judging, with some early effects sooner. Atomoxetine builds gradually, which is its nature, not a failure. People who expect stimulant-speed results quit too early; people properly coached through the ramp often do very well on it.

It shouldn’t, and if it does, the prescription needs adjusting. The goal is you with less friction, not a different person. Some people feel subdued or flat on the wrong dose or medication; that’s a signal to change something, and follow-up visits exist exactly for that conversation. You always stay in the loop on what you’re taking and why.

For most adults, yes, with monitoring. Stimulants have one of the longest track records in psychiatry. Long-term studies show small increases in blood-pressure-related risk, which is why ongoing care here includes cardiovascular monitoring rather than prescribe-and-forget. The comparison that matters is against untreated ADHD, which carries its own well-documented risks: accidents, depression, substance use, and career damage.

Some people need dose adjustments over time, and a smaller group experiences real tolerance. Often what looks like tolerance is actually life changes, sleep debt, or the honeymoon contrast fading. The fixes are methodical: verify sleep and basics, adjust dose or timing, switch families (amphetamine to methylphenidate or vice versa), or add non-medication supports. Escalating on your own is never the answer.

No and mostly yes. Medication works while you take it; it’s a tool, not a life sentence, and plenty of people use it for seasons of life. Stimulants can generally be stopped without a dangerous withdrawal, though you may feel flat or foggy for a few days and your ADHD symptoms return. Atomoxetine is better tapered. Either way, loop your prescriber in so the plan stays coherent.

Usually yes, with specific exceptions a prescriber checks (MAOIs are the hard no; a few combinations need closer monitoring). Treating ADHD alongside anxiety or depression is extremely common, since about half of adults with ADHD have an anxiety disorder. Bring a complete medication list to your evaluation, including supplements.

Under current federal rules, yes: DEA flexibilities extended through at least December 31, 2026 allow licensed prescribers to prescribe ADHD medications, including stimulants, via telehealth after a real-time video evaluation, with no prior in-person visit. Maine law also permits it. At this practice, any prescription follows a comprehensive evaluation and is issued only when clinically appropriate. Federal rules are subject to change, and care plans follow the law as it stands.

No, and you should be suspicious of anyone who does. A guaranteed prescription means the evaluation is theater. Here, the evaluation is real: if ADHD is confirmed and medication fits your situation, medication is on the table, including stimulants when appropriate. If not, you’ll get an honest answer and a plan that fits what’s actually going on. That policy is why the diagnosis you get here is worth something. More on our approach: medication management.

As of mid-2026 the shortage has improved substantially but not vanished; the DEA raised production quotas and generic Vyvanse has eased pressure, yet spot shortages still happen at individual pharmacies and doses. When it happens to you, I work it with you: calling alternatives, switching to an available equivalent when clinically appropriate, or adjusting formulation. You won’t be left chasing refills alone.

Prescribed amphetamines will show as amphetamines on a standard screen; that’s chemistry, not wrongdoing. With a valid prescription, the medical review officer verifies it and reports the test as negative. Practical advice: disclose your prescription through the proper channel when asked, keep your pharmacy label, and if your job has safety-sensitive federal rules (DOT, for example), tell your prescriber so documentation is handled correctly.

Usually in moderation, yes, but stack them thoughtfully. Caffeine and stimulants both raise heart rate and blood pressure, and together they can amplify jitteriness, anxiety, and sleep problems. Many people naturally drop to one morning coffee or switch to decaf after starting medication because the caffeine was self-medication all along. If you’re a heavy caffeine user, mention it during your evaluation.

Light, occasional drinking is generally compatible with stimulant treatment for most adults, but there’s a real caution: stimulants can mask how drunk you feel, making it easier to overdrink. Skip taking a dose specifically to party longer, never mix medication with heavy drinking, and be honest with your prescriber about your actual drinking so the plan reflects reality instead of a brochure.

Schedule II controlled substances legally cannot have refills; each month requires a new prescription, and pharmacies enforce fill dates strictly. Some states and insurers allow up to 90 days via multiple prescriptions, but monthly is the common rhythm, especially during dose adjustment. It’s friction by design, and this practice keeps the monthly process smooth for established patients rather than making you re-earn your treatment every 30 days.

It genuinely goes both ways, which is why the evaluation matters. When anxiety is downstream of untreated ADHD (the constant dropped balls and near-misses), treating ADHD often shrinks the anxiety. When anxiety is independent, a stimulant can crank it up, and the plan may start with a non-stimulant, treat the anxiety first, or pair treatments. This decision is made with you, based on your actual history, not a flowchart.

You have real ones, and your preference is respected here, not argued with. FDA-approved non-stimulants (atomoxetine, viloxazine, guanfacine ER) help many adults meaningfully. Structured skills work, coaching approaches, exercise, and sleep repair add real effect. Some patients use no medication at all and build their plan on structure and therapy. The treatment page covers how these choices get made together.

Medication can meaningfully reduce core ADHD symptoms, but it doesn’t teach the skills built up over years of coping differently. Real treatment usually means medication and ongoing work — building systems, understanding your own patterns, and learning what actually works for your brain. Success isn’t “no more ADHD” — it’s fewer things falling through the cracks and a life that finally fits.

ADHD (attention-deficit/hyperactivity disorder) is a neurodevelopmental condition affecting the brain systems that regulate attention, impulse control, and activity level. It begins in childhood, frequently persists into adulthood, and currently affects about 6% of U.S. adults, roughly 15.5 million people. It has nothing to do with intelligence or effort; it’s a difference in the brain’s management system, and it’s highly treatable.

Overwhelmingly genetics, with brain development differences in the circuits handling attention and self-regulation; heritability is estimated at 74 to 88 percent, among the highest in psychiatry. Prenatal factors and very early environment contribute modestly. Screens, sugar, vaccines, and parenting styles do not cause ADHD, whatever the comment sections claim.

Strongly; it runs in families as robustly as height does. If a parent has ADHD, each child has roughly a coin-flip chance, and siblings of someone with ADHD are many times likelier to have it. This is why one family member’s diagnosis so often triggers a cascade; a parent filling out their child’s evaluation forms recognizing themselves is one of the most common doorways into adult diagnosis.

Yes, among the most validated in psychiatry: recognized by the CDC, NIMH, the American Psychiatric Association, and the World Health Organization, with a century of clinical literature, consistent brain-imaging group findings, and massive twin-study evidence. The debate worth having is about diagnostic access and rigor, not whether ADHD exists.

Classification-wise it’s a neurodevelopmental disorder, present from childhood as a difference in brain development rather than an illness that strikes. Colloquially it falls under mental health care because psychiatric clinicians treat it. Many patients find the neurodevelopmental framing more accurate and less stigmatizing: a brain wired differently, with real costs that treatment reduces.

Legally, often yes: the ADA covers ADHD when it substantially limits major life activities, entitling you to reasonable workplace and academic accommodations. Practically, whether you experience it as a disability varies by person, environment, and support. Both things are true: real impairment deserving legal protection, and a livable, treatable difference.

The honest answer is both directions at once: diagnoses have risen, and some quick-quiz telehealth operations deserved the criticism they got, while large groups, women, adults, people of color, remain demonstrably underdiagnosed; over half of diagnosed adults were missed for their entire childhood. The solution isn’t fewer diagnoses; it’s more rigorous ones, which is why this practice runs 90-minute evaluations with objective testing instead of checklists.

ADD is simply the outdated name; since 1994 everything falls under ADHD with three presentations: predominantly inattentive (the old ADD), predominantly hyperactive-impulsive, and combined. People who say “I have ADD” usually mean inattentive-presentation ADHD, and clinicians know exactly what they mean.

Predominantly inattentive (distractibility, disorganization, forgetfulness, mental drift), predominantly hyperactive-impulsive (restlessness, interrupting, acting before thinking), and combined, which is the most common in adults. Presentation can shift over a lifetime; hyperactivity in particular tends to internalize into restlessness with age. The label matters less than mapping your actual symptom profile to a plan.

On group averages, yes: imaging research shows differences in the development and connectivity of attention and self-regulation networks, and in dopamine signaling, which is precisely where medications act. But no scan diagnoses an individual; the differences are statistical, not a lab test. The practical takeaway is simpler: ADHD is neurobiology, not a character flaw.

No, and be wary of anyone selling a cure. ADHD is a lifelong neurodevelopmental trait; what changes dramatically with treatment is its cost. Between medication, skills, structure, and self-understanding, most adults get their symptoms managed to the point where ADHD stops steering their life. Not cured; well-run.

Diagnoses are rising; the best evidence says the underlying condition isn’t, at least not dramatically. What’s changed is recognition: adult presentations taken seriously, women finally counted, stigma receding, and telehealth removing access barriers. Today’s numbers (6% of U.S. adults) look less like an epidemic and more like an undercount correcting itself.

Research consistently shows that adults with untreated ADHD face a higher risk of accidents and injuries — including on the road — throughout adulthood, not just childhood. Treatment, including medication when appropriate, has been shown to meaningfully reduce that risk. Left unaddressed, ADHD also tends to compound other things over time: anxiety, strained relationships, career setbacks, and difficulty keeping up with routine health care.

More often inattentive and internal: chronic overwhelm, disorganization behind a composed exterior, mental exhaustion from tracking everything, emotional flooding, and shame that’s been misread as anxiety or depression for years. Hyperactivity, when present, tends to look like nonstop talking, overcommitting, and a racing mind rather than bouncing off walls. Because that presentation doesn’t match the disruptive-boy stereotype, it gets missed.

Three compounding reasons: girls skew toward the quieter inattentive presentation that doesn’t trigger referrals; girls are socialized to mask and compensate harder; and the diagnostic research was historically built on boys. The result is women diagnosed a decade or more later than men, often after burnout, a misdiagnosis trail of anxiety and depression, or their own child’s evaluation holds up a mirror.

Meaningfully, yes. Estrogen supports dopamine signaling, the same system ADHD medications target, so when estrogen drops, before periods, postpartum, and through perimenopause, ADHD symptoms often intensify and medication can feel less effective. This is an active research area and a routine clinical reality in this practice; cycle-related patterns are worth tracking and raising at follow-ups.

Perimenopause is the usual answer. Declining estrogen degrades the dopamine support your coping systems quietly depended on, and 2025 research found perimenopausal cognitive symptoms hit earlier and harder in women with ADHD. Women who compensated successfully for decades suddenly can’t, and many get their first diagnosis in this window. It’s not decline; it’s unmasking, and it’s treatable.

The differentiator is the timeline. ADHD symptoms trace back to childhood and early adulthood, even if they were manageable then; perimenopause brain fog arrives with the hormonal transition in a woman whose earlier history was genuinely clear. And often it’s both at once, which changes the treatment conversation. A careful history plus objective testing sorts this out, and it’s a question this practice takes seriously rather than waving off.

Estrogen falls in the late luteal phase, taking dopamine support down with it, so focus, mood, and medication effectiveness commonly dip in the week before a period. For some women with PMDD the interaction is stronger still. Tracking symptoms against your cycle for two or three months produces genuinely useful data; some patients and prescribers adjust plans around the pattern.

This is an individualized risk-benefit decision made with your prescriber and OB, not a blanket yes or no. Data on stimulants in pregnancy is reassuring in some respects and limited in others, and untreated ADHD carries its own real risks. What you shouldn’t do is stop abruptly in a panic or make the call alone. If pregnancy is possible or planned, raise it early so the plan is thought through, not improvised.

Because a generation of missed cases is finally being found. Awareness of how ADHD presents in women, more clinicians who take adult presentations seriously, and frankly, women recognizing themselves in each other’s stories have brought diagnoses that should have happened at 12 to women who are 38. The research consensus is that this is underdiagnosis correcting, not a fad inflating.

Masking is the full-time job of appearing fine: elaborate list systems, triple-checking, arriving early out of fear, rehearsing casualness, saying yes to everything, apologizing constantly. It works until it doesn’t; the collapse usually arrives with a load increase like a promotion, a baby, or perimenopause. Masking is also why women get told “you can’t have ADHD, you’re so organized.” The organization is the symptom.

Yes. Many adults hide ADHD behind effort, perfectionism, and tight systems. Others are told it’s anxiety or depression, which can look similar and often occur alongside ADHD. That’s why I look at your full history instead of relying on how you appear. Doing well doesn’t rule ADHD out, and it doesn’t confirm it either.

ADHD hidden by compensation. It’s not a separate diagnosis. It describes adults whose coping strategies, such as extra reminders, last-minute pressure, and long hours, cover symptoms until life gets busier. A thorough evaluation looks past the coping to the pattern underneath.

The evidence-backed non-medication stack: structured skills training or CBT adapted for ADHD, externalized systems (calendars, alarms, visible lists), body doubling, exercise, protected sleep, and coaching. Honest framing: medication is the single most effective treatment for most adults, but the skills-and-structure layer is what makes gains stick, and a medication-free plan is a legitimate choice this practice will build with you rather than argue against.

Yes, with the right kind: CBT adapted for adult ADHD, which is concrete and systems-focused (task initiation, time management, emotional regulation), has solid evidence, especially combined with medication. Traditional insight-only talk therapy tends to underperform for core ADHD symptoms. Therapy also earns its keep on what rides along: anxiety, shame, and relationship strain.

Coaches are practical accountability partners for building routines and working with your brain; think personal trainer for executive function rather than clinician. Unregulated field, so vet credentials and fit, but for many adults coaching is the bridge between knowing what to do and doing it. It complements medical treatment rather than replacing it.

Modestly at best. Omega-3s show a small but real effect in meta-analyses, worth considering as an add-on, never a substitute. Magnesium, zinc, and vitamin D matter mainly when you’re deficient. Nothing sold as a natural Adderall performs like the marketing. Tell your prescriber everything you take, since even supplements interact.

Genuinely, yes; aerobic exercise acutely boosts the same dopamine and norepinephrine systems ADHD medications target, and regular exercise measurably improves attention, mood, and sleep. It’s a legitimate force multiplier alongside treatment. The ADHD-realistic advice: pick something you actually enjoy, make it social or scheduled, and let it be ten minutes on bad days.

No special diet treats ADHD, and the sugar-causes-hyperactivity idea has failed controlled studies repeatedly. What’s real: protein at breakfast steadies the morning, big blood-sugar swings feel bad in any brain, stimulants suppress appetite (so eat before your dose), and severe restriction diets are more burden than benefit. Boring answer, but it’s the true one.

A little, which is why so many undiagnosed adults arrive running on a six-coffee protocol; caffeine weakly hits the right neurotransmitters. But it’s a blunt tool: short duration, jitters, sleep sabotage, and it stops masking anything once real treatment starts. Most patients naturally downshift caffeine after starting medication. Mention your true intake at the evaluation; it’s diagnostic information.

ADHD brains commonly run delayed body clocks plus can’t-shut-off minds, and revenge bedtime procrastination (staying up to finally have quiet time) is practically an ADHD signature. It’s a vicious cycle, since sleep deprivation mimics and magnifies ADHD. Sleep gets asked about in every evaluation here because no medication outruns four hours of sleep, and treating the ADHD often makes earlier sleep finally achievable.

Evidence supports modest real benefits for attention and emotional regulation, with an asterisk: telling an ADHD brain to sit silently for 30 minutes is a setup. What works is ADHD-adapted practice: short sessions, guided apps, walking meditation, breath checks between tasks. Think strength training for the attention muscle, useful alongside treatment, not a standalone cure.

High-yield examples: written instructions after meetings, noise-canceling headphones or quiet workspace, flexible start times, deadline check-ins broken into stages, protected focus blocks, and permission to record meetings. Under the ADA, reasonable accommodations are a legal right at employers with 15 or more staff when ADHD substantially limits major life activities. Documentation from a proper evaluation is what makes the request land, and established patients can request documentation of their diagnosis here.

Disclose strategically, not confessionally. You only need formal disclosure to invoke ADA accommodations, and even then to HR rather than the whole office. Many people instead request specific supports without naming a diagnosis (“I work best with written follow-ups”). Consider disclosure when accommodations require it or performance conversations have started; skip it when informal adjustments already work.

Under the ADA, yes, when it substantially limits major life activities, which qualifies you for reasonable workplace accommodations, not a parking placard or automatic benefits. Social Security disability for ADHD alone is rare. The practical takeaways: your job rights are real, requesting accommodations is protected, and firing someone for having ADHD (versus performance) is illegal.

Time blindness is the ADHD difficulty sensing time passing and estimating how long things take, which produces the classic paradox: chronically late and paradoxically absurdly early, always shocked by the clock. The fix is externalizing time: visible analog clocks, alarms for transitions (not just endpoints), timers during tasks, and padding every estimate. It’s neurology, not disrespect, though it reads as disrespect to others, which is worth explaining to the people you love.

RSD describes the disproportionately intense emotional pain many people with ADHD feel from criticism, rejection, or even imagining disapproval; moments others shrug off can hit like physical injury. It’s not an official diagnosis but maps onto the emotional dysregulation most adults with ADHD report. It responds to ADHD treatment, sometimes to specific medications like guanfacine, and to simply having a name for it.

The symptoms translate badly: forgetting requests reads as not caring, interrupting reads as not listening, uneven task completion reads as unfairness, and partners drift into a parent-child dynamic nobody wants. Diagnosis often helps couples reframe years of conflict as symptom management instead of character judgment. Treatment plus explicit systems (shared calendars, divided domains) does real repair work.

Money management is executive function with a credit limit: impulse purchases deliver the dopamine hit ADHD brains chase, future consequences are abstract, and admin tasks like bill-paying are exactly what ADHD avoids. Late fees have been called the ADHD tax. What helps: automate everything automatable, add friction to spending (24-hour rules, no saved cards), and treat the underlying ADHD, which measurably improves financial behavior.

The cyclical crash from sustained overcompensation: masking, deadline adrenaline, and heroic catch-up efforts until the system gives out into exhaustion, shutdown, and shame, then a partial recovery and repeat. It’s distinct from job burnout because the load is neurological, not just occupational. Treatment interrupts the cycle at its source by lowering the daily cost of functioning. Related reading: ADHD, Anxiety, or Burnout?

Yes, measurably: untreated ADHD is associated with significantly higher crash and citation rates, and it’s one of the most practical arguments for treatment, which research shows reduces accident risk substantially. Useful habits regardless: phone in the glovebox, medication timed to cover commutes, and extra caution on long boring drives, which are the ADHD danger zone.

Urgency is the one switch that reliably turns on an ADHD brain: panic supplies the neurochemistry that boring importance doesn’t. The all-nighter rescue is a real skill and an expensive one, paid in stress hormones, sleep, and quality. Treatment plus manufactured urgency (body doubling, short timers, staged deadlines with witnesses) lets you borrow the switch without the crash.

Working alongside another person, in the room or on a video call, whose presence anchors your attention; the technique is beloved in the ADHD community because it works startlingly well for many people. Zero cost, no side effects. Formats range from a friend co-working at your kitchen table to online body-doubling communities that run structured sessions all day.

Look at what the mind is doing when focus fails: anxiety hijacks attention with worry (rehearsing, catastrophizing, scanning), while ADHD scatters attention regardless of emotional weather, including during calm. Anxiety typically has an arc tied to stressors; ADHD is a lifelong trait across settings. From the inside they feel similar, which is why evaluation here screens for both. Full comparison: ADHD, Anxiety, or Burnout?

Very commonly; roughly half of adults with ADHD also meet criteria for an anxiety disorder. Sometimes the anxiety is secondary, built from years of ADHD near-misses, and improves when the ADHD is treated. Sometimes it’s independent and needs its own treatment. Both get identified in a proper evaluation, and both are treated here as one coherent plan rather than in silos.

It’s a well-worn path: years of underperforming your own potential, damaged self-esteem, and chronic overwhelm are fertile ground for depression, and adults with ADHD show substantially elevated depression rates. Order of treatment matters and is individualized: severe depression may need attention first; moderate low mood often lifts substantially once the ADHD driving daily failure gets treated.

They’re distinct neurodevelopmental conditions that overlap heavily: studies suggest a large minority of people with one meet criteria for the other, and “AuDHD” is the community’s term for having both. Crudely, ADHD is primarily about attention and impulse regulation; autism centers on social communication differences, sensory processing, and need for sameness. This practice evaluates ADHD and screens broadly; when a full autism assessment is indicated, you’ll get a straight referral.

It can go either direction, which is why the evaluation matters more than the worry. Anxiety that’s downstream of untreated ADHD often improves with stimulant treatment; independent anxiety can be amplified by stimulants, pointing toward non-stimulants, treating anxiety first, or careful pairing. Your history decides this, and it’s monitored at every follow-up rather than assumed.

Severity sets the order. Active severe depression, especially with safety concerns, takes priority. With mild-to-moderate low mood alongside clear ADHD, treating the ADHD often improves both, because daily functioning is the depression’s fuel line. Frequently both are addressed in parallel; stimulants and most antidepressants combine safely under monitoring.

Yes; hypervigilance, concentration problems, and emotional dysregulation from trauma can mimic ADHD closely, and the two also co-occur. The differentiators live in the history: ADHD traces to early childhood across settings, while trauma symptoms organize around events and carry features like intrusive memories. My approach is trauma-informed, and the evaluation asks about this directly instead of pretending the question doesn’t exist.

ADHD is a constant trait; bipolar is episodic. ADHD mood shifts are fast, reactive to events, and hours long; bipolar mood episodes last days to weeks, arrive with changed sleep need and energy, and depart. The distinction matters enormously for medication safety, which is why the evaluation screens for bipolar history before any stimulant discussion.

Untreated ADHD roughly doubles substance-use-disorder risk; impulsivity plus self-medication is the mechanism. Here’s the counterintuitive evidence: appropriate ADHD treatment, including stimulants, is associated with lower substance-use risk, not higher. A use history isn’t a disqualifier at this practice; it’s information that shapes a safer plan, sometimes via non-stimulants.

This is one of the most common stories in adult ADHD, especially for women: the visible anxiety got treated while the ADHD generating it went unexamined, so relief always felt partial. If your anxiety treatment helped but the disorganization, time blindness, and mental scatter never budged, that residue is worth evaluating properly. The answer changes the entire treatment strategy.